Report ScoutReport Scout
Directory
Log in

Company Profile

Astellas Pharma

4503

Astellas Pharma is a Specialty Chemicals company in the Healthcare sector, headquartered in JPN. This page tracks verified corporate disclosures including annual reports, ESG reports, sustainability filings, and financial statements.

The latest annual report from Astellas Pharma tracked by Report Scout is the 2025 Integrated report. In total, Report Scout tracks 4 verified Astellas Pharma reports (2016–2025), with verified links to the official PDF documents.

Subscribe to alerts for Astellas Pharma

Country

JPN

Exchange

TSE

Sector

Healthcare

Industry

Specialty Chemicals

Archive

4 reports (2016–2025)

Most Recent Report

Astellas Pharma 2025 Integrated

Download Astellas Pharma 2025 Integrated PDFView Astellas Pharma 2025 Integrated Web Page

Reports

4 total

Available reports

Annual reports, ESG disclosures, sustainability reports, financial filings, and other corporate documents published by Astellas Pharma.

YEARS

2025

1 report
Integrated

Astellas Pharma Integrated 2025

Astellas Pharma 2025 Integrated PDFAstellas Pharma 2025 Integrated Web Page

2024

1 report
Annual

Astellas Pharma Annual 2024

Published 2025-01-27

Astellas Pharma 2024 Annual PDF

2018

1 report
Annual

Astellas Pharma Annual 2018

Period: Fiscal 2017

Published 2018-09-18

Astellas Pharma 2018 Annual PDF

2016

1 report
Annual

Astellas Pharma Annual 2016

Astellas Pharma 2016 Annual PDF

FAQ

Frequently asked questions

When was Astellas Pharma's latest annual report published?

The most recent annual report from Astellas Pharma tracked by Report Scout is the 2025 Integrated report. New filings are added automatically once discovered and verified.

Where can I download Astellas Pharma's reports as PDF?

This page lists 4 verified Astellas Pharma reports (2016–2025) with direct links to the official PDF documents published by the company.

Does Report Scout track Astellas Pharma's sustainability and ESG reports?

No Astellas Pharma sustainability or ESG report has been verified yet. Subscribe on this page to be emailed as soon as one is published and discovered.